BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
48 results:

  • 1. A meta-analysis of total thyroidectomy and lobectomy outcomes in papillary thyroid microcarcinoma.
    Bi J; Zhang H
    Medicine (Baltimore); 2023 Dec; 102(50):e36647. PubMed ID: 38115346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
    Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
    Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
    Wukich DK; Frykberg RG; Kavarthapu V
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk-stratified Distant Metastatic thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
    Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
    Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
    Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
    Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cardiovascular and thyroid Late Effects in Pediatric Patients With Hodgkin Lymphoma Treated With ABVD Protocol.
    Ali N; Selim M; Salah Z; El Nabarawy NM; Hussein H; Sidhom I
    J Pediatr Hematol Oncol; 2023 May; 45(4):e455-e463. PubMed ID: 36898022
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
    Sandilos G; Lou J; Butchy MV; Gaughan JP; Reid L; Spitz FR; Beninato T; Moore MD
    Am J Surg; 2023 Jul; 226(1):53-58. PubMed ID: 36775791
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
    Monzani ML; Piccinini F; Boselli G; Corleto R; Margiotta G; Peeters RP; Simoni M; Brigante G
    J Endocrinol Invest; 2023 Feb; 46(2):319-326. PubMed ID: 35988109
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.
    Zhang F; Zheng J; Li Y; Wang G; Wang M; Su Y; Gu J; Li X; Bass D; Chu M; Curtis P; DeRose K; Kurrasch R; Lowe J; Meizlik P; Roth DA
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35428697
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Correlation of conventional ultrasound features and related factors with BRAFV600E gene mutation in papillary thyroid carcinoma].
    Lv Y; He X; Yang F; Guo L; Qi M; Zhang J; Wang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):925-929. PubMed ID: 34628817
    [No Abstract]    [Full Text] [Related]  

  • 13. Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions.
    Martins MB; de Assis Batista F; Marcello MA; Bufalo NE; Peres KC; Morari EC; Soares FA; Vassallo J; Ward LS
    Ann Diagn Pathol; 2021 Aug; 53():151766. PubMed ID: 34111705
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary thyroid cancer Patients With Central Neck Metastasis?
    Han K; Noh HM; Jeong HM; Lim YC
    Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.
    Akhtar S; Khafaga Y; Edesa W; Al-Mubarak M; Rauf MS; Maghfoor I
    Hematology; 2021 Dec; 26(1):103-110. PubMed ID: 33478377
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules.
    Jin H; Lin W; Lu L; Cui M
    Eur J Endocrinol; 2021 Jan; 184(1):131-141. PubMed ID: 33112273
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Two-week rule: suspected head and neck cancer referrals from a general medical practice perspective.
    Talwar C; McClune A; Kelly D; Lowe D; Rogers SN
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):981-985. PubMed ID: 32682652
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM
    Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rash management and treatment persistence of cancer patients treated with epidermal growth factor receptor inhibitors in the Truven MarketScan
    Chen L; Brown J; Marmaduke DQ; Mayo C; Grau G; Lau YK; Obasaju CK
    Support Care Cancer; 2018 Jul; 26(7):2369-2377. PubMed ID: 29423677
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. akt2 contributes to increase ovarian cancer cell migration and invasion through the akt2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.